Treatment of Scabies
Permethrin 5% cream applied from the neck down for 8–14 hours (typically overnight) is the first-line treatment for uncomplicated scabies in patients ≥2 months old, with oral ivermectin 200 μg/kg (repeated in 2 weeks) serving as an equally effective alternative or for institutional outbreaks. 1
First-Line Treatment Options
Topical Permethrin 5% Cream
- Apply to all areas of the body from the neck down, leave on for 8–14 hours, then wash off; a single application is generally curative 1
- In infants and young children ≤2 years, apply to the entire body including scalp, hairline, forehead, temples, and neck—not just neck-down as in adults 2
- Permethrin is the preferred agent for pregnant and lactating women due to limited safety data for ivermectin in these populations 3, 1
- For infants <2 months, permethrin remains first-line with 100% complete resolution rates in this age group 4
Oral Ivermectin
- Dose: 200 μg/kg orally, repeated in 2 weeks 1, 5
- Must be taken with food to increase bioavailability and epidermal penetration 1, 5
- Contraindicated in children weighing <15 kg or <10 years old due to potential blood-brain barrier penetration and neurotoxicity 3, 2
- No dosage adjustment needed for renal impairment 5
- Particularly useful when topical application is impractical (e.g., institutional outbreaks, extensive dermatitis) 1, 6
Alternative Topical Agents (when permethrin unavailable or fails)
- Sulfur 6% ointment: Applied nightly for 3 consecutive nights; safest option for infants <2 months 1, 7
- Benzyl benzoate 25%: ~87% cure rate but causes burning sensation in ~43% of patients 2
- Crotamiton 10% cream: Applied nightly for 2 nights, ~60% cure rate versus ~89% for permethrin 2
Special Populations and Clinical Scenarios
Crusted (Norwegian) Scabies
- Requires aggressive combination therapy: Topical permethrin 5% cream applied daily for 7 days, then twice weekly until cure, PLUS oral ivermectin 200 μg/kg on days 1,2,8,9, and 15 1, 2
- Single-application permethrin or single-dose ivermectin alone will fail due to massive mite burden (thousands to millions of mites) and thick crusts that prevent drug penetration 1
- Mandatory specialist consultation for management 3, 1
- Common in immunocompromised patients (HIV, debilitated, malnourished) who require closer monitoring 3, 1
Pregnant and Lactating Women
- Permethrin 5% cream is the preferred treatment 3, 1
- Ivermectin is classified as "low risk" based on limited human data but permethrin remains first choice 3, 5
Infants <2 Months
- Permethrin 5% cream is recommended; apply to entire body including head and neck 2
- Sulfur 6% ointment is the safest alternative if permethrin is unavailable 1, 7
- Ivermectin is absolutely contraindicated due to neurotoxicity risk 2
- Lindane must never be used 2
Contact and Environmental Management
Simultaneous Treatment of All Contacts
- All household members, sexual partners, and close personal contacts within the preceding month must be treated simultaneously, even if asymptomatic 3, 1
- Scabies has a 4–6 week incubation period during which infected persons remain contagious despite being asymptomatic—untreated contacts are the most common cause of treatment failure 1
- Treating only the symptomatic index case permits asymptomatic household members to reinfect the patient within days to weeks 1
Environmental Decontamination
- Machine-wash and dry all bedding, clothing, and towels on hot cycles, or dry-clean them 3, 1
- Alternatively, remove items from body contact for at least 72 hours (mites cannot survive off-host beyond this period) 1, 2
- Fumigation of living areas is unnecessary 1, 2
Follow-Up and Management of Persistent Symptoms
Expected Post-Treatment Course
- Pruritus and rash may persist for up to 2 weeks after successful treatment due to allergic dermatitis—this does NOT indicate treatment failure 3, 1
- Topical corticosteroids (e.g., triamcinolone) and oral antihistamines can relieve post-treatment pruritus, but only AFTER confirming no live mites are present 1
- Do not apply corticosteroids during active treatment, as they may suppress the inflammatory response that helps identify active infestation 1
Retreatment Criteria
- Consider retreatment only after 2 weeks if symptoms persist beyond this period OR live mites are observed 3, 1
- Use an alternative regimen (switch between permethrin and ivermectin) for those who do not respond to initial treatment 3, 1
- Premature retreatment within the first 2 weeks based solely on persistent itching should be avoided 1
Causes of Treatment Failure
- Improper application of topical agents (inadequate coverage, insufficient contact time) 8
- Failure to repeat ivermectin dose after 2 weeks 5, 8
- Reinfection from untreated contacts or contaminated fomites 3
- Incomplete decontamination of bedding and clothing 3, 8
- Absence of written instructions explaining treatment modalities 8
Institutional Outbreaks
- Treat the entire at-risk population simultaneously—control can only be achieved by treating everyone 3, 1
- Mass oral ivermectin administration is recommended for ease of delivery in nursing homes, hospitals, and residential facilities 3, 1, 6
- Manage outbreaks in consultation with a specialist 3, 1
Treatments to Avoid
Lindane
- Never use lindane in children <10 years, pregnant or lactating women, or persons with extensive dermatitis due to risk of neurotoxicity (seizures) and aplastic anemia 3, 1, 2
- Applying lindane after bathing increases systemic absorption and toxicity 1, 2
- Lindane has the highest toxicity profile among scabicidal agents and is strongly discouraged 1
Common Pitfalls to Avoid
- Failure to treat asymptomatic sexual partners and household contacts simultaneously—the most frequent cause of reinfection 1
- Forgetting the second dose of ivermectin at 2 weeks—mandatory due to limited ovicidal activity 5
- Taking ivermectin on an empty stomach—markedly reduces absorption 1, 5
- Expecting immediate resolution of symptoms—post-treatment pruritus is normal for up to 2 weeks 3, 1
- Using single-application permethrin for crusted scabies—will fail due to massive mite burden 1
- Inadequate application of topical permethrin (missing finger webs, genitals, under nails) 8